These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
505 related articles for article (PubMed ID: 30782144)
1. The role of maternal homocysteine concentration in placenta-mediated complications: findings from the Ottawa and Kingston birth cohort. Chaudhry SH; Taljaard M; MacFarlane AJ; Gaudet LM; Smith GN; Rodger M; Rennicks White R; Walker MC; Wen SW BMC Pregnancy Childbirth; 2019 Feb; 19(1):75. PubMed ID: 30782144 [TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study. Boutin A; Guerby P; Gasse C; Tapp S; Bujold E Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265 [TBL] [Abstract][Full Text] [Related]
3. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review. Ray JG; Laskin CA Placenta; 1999 Sep; 20(7):519-29. PubMed ID: 10452905 [TBL] [Abstract][Full Text] [Related]
4. First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease. Dinglas C; Afsar N; Cochrane E; Davis J; Kim S; Akerman M; Wells M; Chavez M; Herrera K; Heo H; Vintzileos A Am J Obstet Gynecol; 2020 May; 222(5):499.e1-499.e6. PubMed ID: 31794723 [TBL] [Abstract][Full Text] [Related]
5. Combining 2nd-trimester maternal serum homocysteine levels and uterine artery Doppler for prediction of preeclampsia and isolated intrauterine growth restriction. Onalan R; Onalan G; Gunenc Z; Karabulut E Gynecol Obstet Invest; 2006; 61(3):142-8. PubMed ID: 16374017 [TBL] [Abstract][Full Text] [Related]
6. Association of Shorter Height with Increased Risk of Ischaemic Placental Disease. Ogawa K; Morisaki N; Saito S; Sato S; Fujiwara T; Sago H Paediatr Perinat Epidemiol; 2017 May; 31(3):198-205. PubMed ID: 28317131 [TBL] [Abstract][Full Text] [Related]
7. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. Rodger MA; Betancourt MT; Clark P; Lindqvist PG; Dizon-Townson D; Said J; Seligsohn U; Carrier M; Salomon O; Greer IA PLoS Med; 2010 Jun; 7(6):e1000292. PubMed ID: 20563311 [TBL] [Abstract][Full Text] [Related]
8. The determinants of maternal homocysteine in pregnancy: findings from the Ottawa and Kingston Birth Cohort. Chaudhry SH; Taljaard M; MacFarlane AJ; Gaudet LM; Smith GN; Rodger M; Rennicks White R; Walker MC; Wen SW Public Health Nutr; 2020 Dec; 23(17):3170-3180. PubMed ID: 32188521 [TBL] [Abstract][Full Text] [Related]
9. Placental Abnormalities and Placenta-Related Complications Following Kong F; Fu Y; Shi H; Li R; Zhao Y; Wang Y; Qiao J Front Endocrinol (Lausanne); 2022; 13():924070. PubMed ID: 35846290 [TBL] [Abstract][Full Text] [Related]
11. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption. Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):48-52. PubMed ID: 21482016 [TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials. Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD; Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497 [TBL] [Abstract][Full Text] [Related]
13. [Multivariate analysis of risk factors with placental abruption in preeclampsia]. Wang YN; Yang Z Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):825-8. PubMed ID: 21211280 [TBL] [Abstract][Full Text] [Related]
14. Platelet activation and placenta-mediated adverse pregnancy outcomes: an ancillary study to the Effects of Aspirin in Gestation and Reproduction trial. Theilen LH; Campbell HD; Mumford SL; Purdue-Smithe AC; Sjaarda LA; Perkins NJ; Radoc JG; Silver RM; Schisterman EF Am J Obstet Gynecol; 2020 Nov; 223(5):741.e1-741.e12. PubMed ID: 32434001 [TBL] [Abstract][Full Text] [Related]
15. First-trimester placental thickness and the risk of preeclampsia or SGA. Vachon-Marceau C; Demers S; Markey S; Okun N; Girard M; Kingdom J; Bujold E Placenta; 2017 Sep; 57():123-128. PubMed ID: 28864000 [TBL] [Abstract][Full Text] [Related]
17. Are Anti-β2 Glycoprotein 1 Antibodies Associated with Placenta-Mediated Pregnancy Complications? A Nested Case-Control Study. Skeith L; Abou-Nassar KE; Walker M; Ramsay T; Booth R; Wen SW; Smith GN; Rodger MA Am J Perinatol; 2018 Sep; 35(11):1093-1099. PubMed ID: 29635655 [TBL] [Abstract][Full Text] [Related]
18. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction. Vatten LJ; Åsvold BO; Eskild A Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089 [TBL] [Abstract][Full Text] [Related]
19. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study. Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323 [TBL] [Abstract][Full Text] [Related]